Poop-testing startup uBiome was once valued at $600 million by Silicon Valley’s top VCs. It just filed for bankruptcy.

Posted in Biotech

September 06, 2019

European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)​ Incorporate Findings From Amarin's REDUCE-IT Cardiovascular Outcomes Study into Practice Guidelines

Posted in Biotech

September 03, 2019 • 4 min read

Over the weekend, the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) updated their Clinical Practice Guidelines for the Management of Dyslipidaemias by incorporating findings from Amarin's the REDUCE-IT cardiovascular outcomes study....